Paper
Cisplatin (cis-diamminedichloroplatinum II).
Published Mar 1, 1979 · A. W. Prestayko, J. C. D'Aoust, B. F. Issell
Cancer treatment reviews
Q1 SJR score
365
Citations
2
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Highly CitedStudy Snapshot
Cisplatin effectively inhibits tumor growth by blocking DNA synthesis, showing significant antitumor activity in various cancers, but has dose-limiting renal toxicity and other side effects.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···